REFERENCES
- Gathe JO, Washington MY, Mayberry C, Piot D, Nemecek J. IMANI-1 TC3WP. Single drug HAART-proof of concept study. Pilot study of the safety and efficacy of Kaletra (LPV/r) as single drug HAART in HIV+ ARV-naïve patients-interim analysis of subjects completing final 48 week data. In: Program and abstracts of the XV International AIDS Conference; July 11–16, 2004; Bangkok, Thailand. Abstract MoOrB1057.
- Ruane P, Luber A, Gaultier C, et al. Maintenance therapy using lopinavir/ritonavir (LPV/r) alone with well-controlled HIV Infection. In: Program and abstracts of the XV Interna-tional AIDS Conference; July 11–16, 2004; Bangkok, Thai-land. Abstract TuPeB4577.
- von Hentig NH, Mueller A, Haber A, et al. The ATSAQ-1 cohort study: pharmacokinetic interactions of atazanavir (AZV) and saquinavir (SQV) in a ritonavir (RTV) boosted protease inhibitor therapy regimen. In: Program and ab-stracts of the XV International AIDS Conference; July 11–16, 2004; Bangkok, Thailand. Abstract WeOrB1235.
- Arasteh K, Lazzariri A, Clotet B, et al. TORO: 96 week virological and immunological response and safety evalu-ation of enfuvirtide with an optimized background regi-men. In: Program and abstracts of the XV International AIDS Conference; July 11–16, 2004; Bangkok, Thailand. Abstract MoOrB1058.
- Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004;351(3):217–218.
- Jourdain G, Ngo-Giang-Huong N, Le Coeur S, et al. Intra-partum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med. 2004;351(3):229–240.
- Ferris DC, Dawood H, Chiasson MA, et al. Self-reported adherence to antiretroviral therapy and virologic out-comes in HIV-infected persons in Durban, KwaZulu Natal, South Africa. In: Programs and abstracts of the XV Inter-national AIDS Conference; July 11–16, 2004; Bangkok, Thailand. Abstract WePeB5829.
- Oyugi JH, Byakika JT, Raglang K, et al. Treatment out-comes and adherence to generic triomune and maxivir therapy in Kampala, Uganda. In: Program and abstracts of the XV International AIDS Conference; July 11–16, 2004; Bangkok, Thailand. Abstract WeOrB1323.